The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glycemic management is primarily assessed with the HbA1c test, which was the measure used in trials demonstrating the bene fi ts of glucose lowering (2,52).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Autoantibody markers are usually present in 85% to 90% of individuals with type 1 diabetes when fasting hyperglycemia is initially detected (2).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chronic diseases, such as T2DM, develop over a long period [102].”
From Digital Health Interventions to Prevent Type 2 Diabetes Mellitus: Systematic Review (2025) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overall, 10 of 42 (24%) patients had a 2-hour plasma glucose level ≥140 mg/dL on the oral glucose tolerance test indicative of impaired glucose tolerance according to the World Health Organization (WHO) and the American Diabetes Association.1”
From Pain and small fiber pathology in men with fibromyalgia syndrome (2024) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As with any laboratory test, HbA1c measurement has limitations (2,52).”
The cited source says what the claim attributes to it.
In the citing paper
“An HbA 1c value of 6.5% (48 mmol/mol) or greater is considered diagnostic.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Depending on the specific MODY mutation, the disease can be mild (e.g., glucokinase mutation) and not usually associated with long term complications of diabetes or as severe as typical type 1 diabetes (e.g., hepatocyte nuclear factor [HNF] mutations) (2).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“responsive to sulfonylureas”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“genitourinary”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“developmental delay and seizures”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“responsive to sulfonylureas”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent or transient: IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“gout”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“HNF1B | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent or transient: IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“HNF1B-MODY”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“atrophy of the pancreas”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“HNF1B-MODY: developmental renal disease”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“KCNJ11 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“developmental delay”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“ABCC8 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: IUGR; insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“hyperuricemia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“INS | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“medications other than insulin”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“GATA6 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“EIF2B1 | AD”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“epiphyseal dysplasia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“mechanisms include UPD6”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“macroglossia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“EIF2AK3 | AR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“pancreatic exocrine”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“fluctuating liver function”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“pancreatic hypoplasia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent diabetes”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“cardiac”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“pancreatic exocrine”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: pancreatic hypoplasia; cardiac”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“immunodysregulation”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“autoimmune diabetes”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: Wolcott-Rallison syndrome”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“6q24 (PLAGL1, HYMA1) | AD for paternal duplications”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“IUGR”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“FOXP3 | X-linked”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Transient: IUGR; macroglossia; umbilical”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Permanent: immunodysregulation,”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“hernia”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“insulin requiring”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“exfoliative”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“autoimmune thyroid disease”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“The efficacy of interventions for primary prevention of type 2 diabetes (22,23) has mainly been demonstrated among individuals who have impaired glucose tolerance (IGT) with or without elevated fasting glucose, not for individuals with isolated impaired fasting glucose (IFG) or for those with prediabetes defined by A1…”
BackgroundDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Flagged first, then by citations
Research works printed but not linked: 1
- International Diabetes Federation . IDF Diabetes Atlas, 9th edition. Brussels, Belgium, International Diabetes Federation, 2019. Accessed 15 October 2020. Available from https://www.diabetesatlas.org/en/
Cited by
Sorted by citations
Items 601–700 of 1,009
Zhou, J. Y., Yan, S., Guo, X., Gao, Y., Chen, S., Li, X., Zhang, Y., Wang, Q., Zheng, T., & Chen, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109543 · Cited by 23
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
Hromić‐Jahjefendić, A., Barh, D., Uversky, V. N., Aljabali, A. A. A., Tambuwala, M. M., Alzahrani, K. J., Alzahrani, F. M., Alshammeri, S., & Lundstrom, K. H. (2023) · Vaccines · doi:10.3390/vaccines11020208 · Cited by 22
Screening and diagnosis of gestational diabetes
White, S. L., Ayman, G., Bakhai, C., Hillier, T. A., & Magee, L. A. (2023) · BMJ · doi:10.1136/bmj-2022-071920 · Cited by 24
Kim, M. J., Song, H., Koh, Y., Lee, H., Park, H. E., Choi, S. H., Yoon, J. W., & Choi, S.-Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1181879 · Cited by 23
Kakavandi, N. R., Mousavi, T., Asadi, T., Moradi, A., Esmaeili, M., Sezavar, A. H., Nikfar, S., & Abdollahi, M. R. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.08.001 · Cited by 21
Zoungas, S., Zhou, Z., Owen, A. J., Curtis, A. J., Espinoza, S. E., Ernst, M. E., Woods, R. L., Orchard, S. G., McNeil, J. J., Murray, A. M., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00327-3 · Cited by 22
Niotis, K., Saperia, C., Saif, N., Carlton, C., & Isaacson, R. (2024) · Nature Mental Health · doi:10.1038/s44220-023-00191-0 · Cited by 20
Current scientific evidence for why periodontitis should be included in diabetes management
Borgnakke, W. S. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1257087 · Cited by 27
Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem
Minniakhmetov, I. R., Yalaev, B. I., Khusainova, R. I., Bondarenko, E. V., Mel'nichenko, G. A., Dedov, I. I., & Mokrysheva, N. G. (2024) · Biomedicines · doi:10.3390/biomedicines12020399 · Cited by 27
A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits
Wong, T. H. T., Mo, J. M. Y., Zhou, M., Zhao, J. V., Schooling, C. M., He, B., Luo, S., & Yeung, S. L. A. (2024) · Communications Biology · doi:10.1038/s42003-024-05977-1 · Cited by 21
Wang, J., Yang, Y., Su, Q., Wang, J., Zeng, H., Chen, Y., Zhou, J., & Wang, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-19521-7 · Cited by 21
Natural Saponins on Cholesterol‐Related Diseases: Treatment and Mechanism
Xiao, M., Li, S., Pei, W., Gu, Y., & Piao, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.8432 · Cited by 21
Type 1 innate lymphoid cells are associated with type 2 diabetes
Liu, F., Wang, H., Feng, W., Ye, X., Sun, X., Jiang, C., Chu, X., Zhang, P., Jiang, C., Wang, Y., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.08.005 · Cited by 21
Type 2 Diabetes in Latino Youth: A Clinical Update and Current Challenges
Cruz, P., & Granados, A. (2018) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2018.11.008 · Cited by 22
Comorbidities in Patients With End-Stage Knee OA: Prevalence and Effect on Physical Function
Kim, W. B., Kim, B. R., Kim, S. R., Han, E. Y., Nam, K. W., Lee, S. Y., Ji, S. M., & Kim, J. H. (2019) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2019.04.005 · Cited by 21
Hertz, J. T., Sakita, F. M., Limkakeng, A. T., Mmbaga, B. T., Appiah, L. T., Bartlett, J. A., & Galson, S. W. (2019) · African Journal of Emergency Medicine · doi:10.1016/j.afjem.2019.07.001 · Cited by 21
Eckstein, M. L., Farinha, J. B., McCarthy, O. M., West, D. J., Yardley, J. E., Bally, L., Züger, T., Stettler, C., Boff, W., Reischak-Oliveira, Á., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1496 · Cited by 28
Papaetis, G. S. (2021) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2021.105314 · Cited by 24
Ischemic stroke and diabetes: a TLR4-mediated neuroinflammatory perspective
Oo, T. T. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02441-9 · Cited by 21
Chen, L., Wu, L., Zhang, L., Sun, B., Wu, W., Yu, L., Zhu, L., Sun, T., Liang, B., Zhao, H., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001872 · Cited by 20
Mondal, R. K., Ritu, R. B., Kitaoka, K., Azahar, N., Moniruzzaman, M., Ogata, S., Kiyoshige, E., Tohara, H., Kobayashi, Y., Kashihara, N., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119074 · Cited by 20
Li, Z., Yu, C., Zhang, H., Chen, R., Zhao, Y., & Zheng, Z. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02537-z · Cited by 20
Predicting diabetic retinopathy based on routine laboratory tests by machine learning algorithms
Wan, X., Zhang, R., Wang, Y., Wei, W., Song, B., Zhang, L., & Hu, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-02442-5 · Cited by 20
Omary, L., Canfora, E. E., Puhlmann, M.-L., Gavriilidou, A., Rijnaarts, I., Holst, J. J., Bruls, Y. M. H., de Vos, W. M., & Blaak, E. E. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102237 · Cited by 22
Is liver glycogen fragility a possible drug target for diabetes?
Li, C., & Hu, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901463rr · Cited by 20
Liu, Z., Tang, J., Cheng, M.-D., Jiang, L.-Z., Guo, Q., Zhang, J., Zhang, Z.-L., Song, F.-H., Wang, K., Fan, L., et al. (2021) · Coronary Artery Disease · doi:10.1097/mca.0000000000001021 · Cited by 20
Kiuchi, M. G., Ganesan, K., Keating, J. H., Carnagarin, R., Matthews, V. B., Herat, L. Y., Goh, G. S., Adams, L. A., & Schlaich, M. P. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01814-1 · Cited by 20
Diabetes outcomes before and during telehealth advancements surrounding COVID-19
Woodhouse, A., Orvin, C., Rich, C., Crosby, J. F., & Keedy, C. A. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.09.011 · Cited by 21
Jin, Y., Chen, Z., Li, J., Zhang, W., & Feng, S. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104271 · Cited by 20
Jiang, S., Di, D., Jiao, Y., Zou, G., Gao, H., & Li, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868127 · Cited by 20
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome
Selen, D. J., & Powe, C. E. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000769 · Cited by 23
Insulin resistance and accelerated cognitive aging
Abbasi, F., Robakis, T. K., Myoraku, A., Watson, K. T., Wroolie, T., & Rasgon, N. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105944 · Cited by 20
Li, S., Xie, H., Shi, Y., & Liu, H. (2022) · Medicine · doi:10.1097/md.0000000000031232 · Cited by 20
Caring for Patients With Diabetes in Stroke Neurology
Kernan, W. N., Forman, R., & Inzucchi, S. E. (2022) · Stroke · doi:10.1161/strokeaha.122.038163 · Cited by 23
Park, C. Y., Kim, D.-U., Seo, M. K., Kim, J., Choe, H., Kim, J.-H., Hong, J. P., Lee, Y. J., Heo, Y., Kim, H. J., et al. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.01.018 · Cited by 20
Chen, Y., Zhao, J., Li, X., Xie, Z., Huang, G., Yan, X., Zhou, H., Li, Z., Xu, T., Zhou, K., et al. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002321 · Cited by 20
Wu, S., Li, L., Hu, K.-L., Wang, S., Zhang, R., Chen, R., Liu, L., Wang, D., Pan, M., Zhu, B., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad052 · Cited by 21
Apple Peel Supplementation Potential in Metabolic Syndrome Prevention
Popiołek-Kalisz, J., & Glibowski, P. (2023) · Life · doi:10.3390/life13030753 · Cited by 22
Elhag, W., Lock, M., & Ansari, W. E. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06528-z · Cited by 20
The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers
Demir, M. E., Özler, T. E., Merhametsiz, Ö., Sözener, U., Uyar, M., Ercan, Z., Bardak, S., Sezer, S., & Sarıyıldız, G. T. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03645-7 · Cited by 23
Belosludtsev, K. N., Serov, D. A., Ilzorkina, A. I., Starinets, V. S., Dubinin, M. V., Talanov, E. Y., Karagyaur, M. N., Primak, A. L., & Belosludtseva, N. V. (2023) · Antioxidants · doi:10.3390/antiox12071459 · Cited by 24
Yu, H., Ho, M. M., Liu, X., Yang, J., Chau, P. H., & Fong, D. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04088 · Cited by 24
Prediabetes in children and adolescents: An updated review
Ng, H. Y., & Chan, T. W. L. (2023) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v12.i5.263 · Cited by 22
Bioengineering and vascularization strategies for islet organoids: advancing toward diabetes therapy
Yang, J., Yan, Y., Yin, X., Liu, X., Reshetov, I. V., Karalkin, P. A., Li, Q., & Huang, R. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155786 · Cited by 22
Kurniawan, F., Sigit, F. S., Trompet, S., Yunir, E., Tarigan, T. J. E., Harbuwono, D. S., Soewondo, P., Tahapary, D. L., & de Mutsert, R. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102629 · Cited by 20
Mone, P., Jankauskas, S. S., Manzi, M. V., Gambardella, J., Coppola, A., Kansakar, U., Izzo, R., Fiorentino, G., Lombardi, A., Varzideh, F., et al. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001253 · Cited by 23
Guo, M., Guo, H., Zhu, J., Wang, F., Chen, J., Wan, C., Deng, Y., Wang, F., Xu, L., Chen, Y., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06098-4 · Cited by 22
Yang, Z., Ma, Y., Wang, Y., Jin, M., Bin, J., Chen, Z., & Teng, Z. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102730 · Cited by 22
Cai, C., Zhu, S., Qin, M., Li, X., Feng, C., Yu, B., Dai, S., Qiu, G., Li, Y., Ye, T., et al. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101100 · Cited by 21
Kaya, A., Koçyiğit, C., Çatlı, G., Özkan, E. B., & Dündar, B. N. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.4031 · Cited by 20
Yoo, J. H., Kim, G., Park, S. W., Choi, M. S., Ahn, J., Jin, S., Hur, K. Y., Lee, M., Kang, M., & Kim, J. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-62841-y · Cited by 20
Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors
Fan, Z., Gong, Y., Huang, Q., Yang, C., He, C., Jin, K., Fan, K., Ni, Q., Yu, X., Luo, G., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001564 · Cited by 20
Early Predictors of Gestational Diabetes Mellitus in IVF-Conceived Pregnancies
Coussa, A., Hasan, H. A., & Barber, T. M. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.020 · Cited by 21
Iser, B. P. M., Pinheiro, P. C., Malta, D. C., Duncan, B. B., & Schmidt, M. I. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021262.34852020 · Cited by 20
What Difference Does a Diagnosis Make? Evidence from Marginal Patients
Alalouf, M., Miller, S., & Wherry, L. (2019) · National Bureau of Economic Research · doi:10.3386/w26363 · Cited by 20
Yu, Z., Zheng, Q., Huang, L., Jiang, X., Gao, X., Li, J., & Liu, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291732 · Cited by 22
Oliveras, L., Coloma, A., Lloberas, N., Lino, L., Favà, A., Manonelles, A., Codina, S., Couceiro, C., Melilli, E., Sharif, A., et al. (2024) · Transplantation Reviews · doi:10.1016/j.trre.2024.100856 · Cited by 19
Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?
Zhou, Z., Mingyue, X., Xiong, P., Yuan, J., Zheng, D., & Piao, S. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01479-6 · Cited by 19
Glucose Counter-regulation After Acute Pancreatitis
Bharmal, S. H., Pendharkar, S. A., Singh, R. G., Cho, J., & Petrov, M. S. (2019) · Pancreas · doi:10.1097/mpa.0000000000001318 · Cited by 19
Zhang, X., Wu, H., Fan, B., Shi, M., Lau, E. S. H., Yang, A., Chow, E., Kong, A. P. S., Chan, J. C. N., Ronald, C. W., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004045 · Cited by 20
Georgoulis, M., Georgousopoulou, E. N., Chrysohoou, C. A., Pitsavos, C. E., & Panagiotakos, D. B. (2022) · Foods · doi:10.3390/foods11162389 · Cited by 20
Calderón-DuPont, D., Torre-Villalvazo, I., & Díaz‐Villaseñor, A. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.021 · Cited by 23
Robles-Rivera, K., Argoty-Pantoja, A. D., Hidalgo‐Bravo, A., Quezada-Sanchez, A. D., León‐Reyes, G., Flóres, Y. N., Salmerón, J., Velázquez‐Cruz, R., & Rivera‐Paredez, B. (2022) · Nutrients · doi:10.3390/nu14204245 · Cited by 19
Mentxaka, A., Gómez‐Ambrosi, J., Ramírez, B., Rodrı́guez, A., Becerril, S., Neira, G., Valentí, V., Moncada, R., Silva, C., Unamuno, X., et al. (2022) · Nutrients · doi:10.3390/nu14204372 · Cited by 21
Mora-Ortiz, M., Alcala-Diaz, J. F., Rangel-Zúñiga, O. A., Larriva, A. P. A.-D., Abollo‐Jiménez, F., Luque-Córdoba, D., Priego‐Capote, F., Malagón, M. M., Delgado‐Lista, J., Ordovás, J. M., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02566-z · Cited by 19
Almutairi, M. G., Aldubayan, K., & Molla, H. N. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3133 · Cited by 19
Cuda, S. E., Censani, M., Kharofa, R. Y., O’Hara, V. M., Conroy, R., Williams, D. R., Paisley, J., Browne, A. F., Karjoo, S., & Browne, N. T. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100048 · Cited by 19
Nabila, S., Kim, J.-E., Choi, J., Park, J., Shin, A., Lee, J., Lee, J., Kang, D., & Choi, J. (2023) · Diabetes Care · doi:10.2337/dc22-1042 · Cited by 20
Ali, M. K., Imperatore, G., Benoit, S. R., O’Brien, M. J., Holliday, C. S., Echouffo-Tcheugui, J. B., & Bullard, K. M. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110572 · Cited by 19
Végh, D., Bencze, B., Bányai, D., Vegh, A., Rózsa, N. K., Dobó‐Nagy, C., Biczó, Z., Kammerhofer, G., Ujpál, M., Agurto, L. D., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064745 · Cited by 23
Jang, J. H., Kim, W., Moon, J. S., Roh, E., Kang, J. G., Lee, S. J., Ihm, S., & Huh, J. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082899 · Cited by 22
Pan, H., Sun, J., Luo, X., Ai, H., Zeng, J., Shi, R., & Zhang, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1136653 · Cited by 19
Ali, H. S., Kamel, M. M., Agwa, S. H. A., Abdel-Hakeem, M. S., El‐Meteini, M., & Matboli, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1131171 · Cited by 19
NF-κB-Inducing Kinase Provokes Insulin Resistance in Skeletal Muscle of Obese Mice
Chen, X., Liu, Z., Liu, W., Wang, S. F., Jiang, R., Hu, K., Sheng, L., Xu, G., Kou, X., & Song, Y. (2023) · Inflammation · doi:10.1007/s10753-023-01820-7 · Cited by 21
Emerging Anti-Diabetic Drugs for Beta-Cell Protection in Type 1 Diabetes
Ajmal, N., Bogart, M. C., Khan, P., Max-Harry, I. M., & Nunemaker, C. S. (2023) · Cells · doi:10.3390/cells12111472 · Cited by 20
Balbi, G. G. M., Ahmadzadeh, Y., Tektonidou, M. G., Pengo, V., Sciascia, S., Ugarte, A., Belmont, M. H., López-Pedrera, C., Fortin, P. R., Wahl, D. G., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead292 · Cited by 19
2D Gallium Sulfide-Based 1D Photonic Crystal Biosensor for Glucose Concentration Detection
Abderrahmane, A., Senouci, K., Hachemi, B., & Ko, P. J. (2023) · Materials · doi:10.3390/ma16134621 · Cited by 19
Ramasubbu, K., & Rajeswari, V. D. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04631-6 · Cited by 20
Han, C. Y., Lim, S. L., Ong, K. W., Johal, J., & Gulyani, A. (2023) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2023.10.005 · Cited by 20
Bian, X., He, J., Zhang, R., Yuan, S., & Dou, K. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s445479 · Cited by 21
High mortality risk among women with acromegaly still persists
Galoiu, S. A., Toma, I.-D., Tanasie, D., Bărbulescu, A., Baciu, I. F., Niculescu, D., Trifanescu, R. A., Capatina, C. A.-M., Radian, S., & Poiană, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1348972 · Cited by 19
Xu, L., Li, D., Song, Z., Liu, J., Zhou, Y., Yang, J., & Wen, P. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2331614 · Cited by 19
Saely, C. H., Schindewolf, M., Zanolin, D., Heinzle, C. F., Vonbank, A., Silbernagel, G., Leiherer, A., Drexel, H., & Baumgärtner, I. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.031 · Cited by 19
Fatima, F., Ahsan, N., Nasim, A., & Alam, F. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.2.1106 · Cited by 19
Romo-Romo, A., Aguilar-Salinas, C. A., López-Carrasco, M. G., Guillén-Pineda, L. E., Brito-Córdova, G. X., Gómez-Díaz, R. A., Gomez-Perez, F. J., & Almeda‐Valdés, P. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2020.03.018 · Cited by 19
Motto, A. E., Lawson-Evi, P., Bakoma, B., Eklu‐Gadegbeku, K., & Aklikokou, K. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06648 · Cited by 19
Management of Obesity in Children and Young People
White, B., & Viner, R. (2022) · doi:10.1093/med/9780198870197.003.0228 · Cited by 19
A diagnostic proposal for sarcopenic obesity in adults based on body composition phenotypes
Zambon Azevedo, V., Ponnaiah, M., Bel Lassen, P., Ratziu, V., & Oppert, J.-M. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.10.010 · Cited by 18
Roles of ferroptosis in type 1 diabetes induced spermatogenic dysfunction
Cao, Y., Jin, Z., Xi, Y., Cheng, J., Fang, Z., Zhao, Q., Weng, J., Zhu, J., Tang, Y., Zhang, Z., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.02.006 · Cited by 19
Mazzotta, F. A., Paoli, L. L., Rizzi, A., Tartaglione, L., Leo, M. L., Popolla, V., Barberio, A., Viti, L., Leo, M. A. S. D., Pontecorvi, A., et al. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00319-w · Cited by 24
Zhou, C., Zhang, Y., Liu, X., He, C., & Li, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1518840 · Cited by 18
Zhang, F., Zhang, B., Huang, X., Wang, Z., Wang, J., Lan, H., Xie, G., Wang, W., Zou, Y., & Wang, C. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02836-8 · Cited by 18
Lai, H., Deng, C., Liao, C., Tian, R., liu, K., Luo, Z., He, L., Tu, H., & Li, J. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03067-y · Cited by 20
Şen, O., Çalıkoğlu, İ., Özgen, G., Toydemir, T., Türkçapar, A. G., & Yerdel, M. A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.07.021 · Cited by 18
Delialis, D., Georgiopoulos, G. A., Aivalioti, E., Mavraganis, G., Dimopoulou, M., Sianis, A., Aggelidakis, L., Patras, R., Petropoulos, Ι., Ioannou, S., et al. (2022) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2022.05.011 · Cited by 18
Kaul, P., Chu, L. M., Dover, D. C., Yeung, R. O., Eurich, D. T., & Butalia, S. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100320 · Cited by 18
Lim, L., Lau, E. S. H., Cheung, J. T. K., Chan, S. P., Ji, L., Lim, S. K., Sirinvaravong, S., Unnikrishnan, A., Luk, A. O. Y., Cortese, V., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14865 · Cited by 18
Rizos, E. C., Kanellopoulou, A., Filis, P., Markozannes, G., Chaliasos, K., Ntzani, E., Tzamouranou, A., Tentolouris, N., & Tsilidis, K. K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221123530 · Cited by 22
Li, C., Shang, S., & Liang, W. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003299 · Cited by 19
Zaromytidou, E., Koufakis, T., Dimakopoulos, G., Drivakou, D., Konstantinidou, S., Rakitzi, P., Grammatiki, M., Manthou, E., Νοτόπουλος, Α., Iakovou, I. P., et al. (2022) · Metabolites · doi:10.3390/metabo12100884 · Cited by 18
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S17-S38
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200148796
- Semantic Scholar
- a1d863e5f4d381bf99eea7ee26e18dcc69f81a15
- Cited by
- 4,792
- References
- 253
- Citations by year
- 2026: 293 · 2025: 689 · 2024: 1026 · 2023: 1164 · 2022: 814 · 2021: 356
- FWCI
- 129.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes classification, diabetes diagnosis, diabetes diagnosis criteria, diabetes subtypes
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
